Evidence map›Paper›PMID 29104255›Full record

ReviewBiomolecules2017

Revealing Accessibility of Cryptic Protein Binding Sites within the Functional Collagen Fibril.

Cody L Hoop, Jie Zhu, Ana Monica Nunes, David A Case, Jean Baum

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Poly(ADP-ribose) binding sites on collagen I fibrils for nucleating intrafibrillar bone mineral.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Real-time single-molecule observation of incipient collagen fibrillogenesis and remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. Article
  8. Regenerative Approaches for the Treatment of Large Bone Defects.Tissue engineering. Part B, Reviews · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cody L HoopDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. cody.hoop@rutgers.edu.ORCID 0000-0003-4441-8321
Jie ZhuDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. zhujiejz39@gmail.com.
Ana Monica NunesDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. anamonicanunes@gmail.com.
David A CaseDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. david.case@rutgers.edu.
Jean BaumDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. jean.baum@rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

NMR STUDIES OF TRIPLE HELICAL PEPTIDESR01GM045302 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BAUM, JEAN S · 1996 to 2019
$4.5M
Solution and solid structures from NMRR01GM045811 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI CASE, DAVID A · 1991 to 2016
$3.7M
NIGMS NIH HHS R01 GM045302NIGMS NIH HHS R01 GM045811
6 · The paper itself

Abstract

Fibrillar collagens are the most abundant proteins in the extracellular matrix. Not only do they provide structural integrity to all of the connective tissues in the human body, but also their interactions with multiple cell receptors and other matrix molecules are essential to cell functions, such as growth, repair, and cell adhesion. Although specific binding sequences of several receptors have been determined along the collagen monomer, processes by which collagen binding partners recognize their binding sites in the collagen fibril, and the critical driving interactions, are poorly understood. The complex molecular assembly of bundled triple helices within the collagen fibril makes essential ligand binding sites cryptic or hidden from the molecular surface. Yet, critical biological processes that require collagen ligands to have access to interaction sites still occur. In this contribution, we will discuss the molecular packing of the collagen I fibril from the perspective of how collagen ligands access their known binding regions within the fibril, and we will present our analysis of binding site accessibility from the fibril surface. Understanding the basis of these interactions at the atomic level sets the stage for developing drug targets against debilitating collagen diseases and using collagen as drug delivery systems and new biomaterials.

Indexed as

Binding SitesCell AdhesionCollagenDrug Delivery SystemsExtracellular MatrixFibrillar CollagensHumansLigandsProtein BindingCollagenFibrillar CollagensLigandscollagenfibrilsinteractionligandsolvent accessible surface area

Identifiers

PMID29104255
PMCPMC5745458
OpenAlexW2765723837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.